- US-listed companies
- Bionik Laboratories Corp.
Bionik Laboratories Corp.BNKL
Market cap
$12.48
P/E ratio
Dec 31, 2011 | Dec 31, 2015 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | |
Revenues, net | - | - | 571,945 | 987,431 | - | - | 1 | 1 | 2 |
Cost of Revenue | - | - | 388,756 | 402,665 | 2 | 893,374 | 269,632 | 320,454 | 815,325 |
Gross Profit | - | - | 183,189 | 584,766 | 2 | 1 | 923,798 | 953,258 | 989,877 |
Sales and marketing | - | - | 1 | 2 | 2 | 2 | 1 | 2 | 2 |
Research and development | - | 1 | 3 | 3 | 3 | 4 | 1 | 998,516 | 903,219 |
General and administrative | 26,249 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 |
Goodwill and Intangible Asset Impairment | - | - | - | - | - | - | 7 | 5 | - |
Total operating expenses | 26,249 | 6 | 9 | 10 | 11 | 12 | 14 | 11 | 6 |
Loss from operations | -4,479 | - | - | - | - | - | -13,337,325 | -9,973,199 | -4,825,039 |
Interest Expense | - | 3,018 | 43,735 | 1 | - | - | 405,279 | 825,209 | 107,150 |
Other expense (income), net | - | - | - | - | - | - | 122,147 | 390,414 | -13,835 |
Total other expense | - | - | - | - | - | - | - | - | -120,985 |
Net loss | -4,661 | -5,593,906 | -3,936,574 | -14,625,790 | 11 | 25 | -13,620,457 | -10,407,994 | -4,946,024 |
Loss per share - basic | - | - | -0.04 | - | - | - | - | -1.78 | -0.72 |
Loss per share - diluted | - | - | -0.04 | - | - | - | - | -1.78 | -0.72 |